Document is current
Any future updates will be listed below
-
Authors
Gupta, Aaron
Kao, Kevin S.
Yamin, Rachel
Oren, Deena A. https://orcid.org/0000-0003-0074-2242
Goldgur, Yehuda
Du, Jonathan
Lollar, Pete
Sundberg, Eric J. https://orcid.org/0000-0003-0478-3033
Ravetch, Jeffrey V. https://orcid.org/0000-0003-2024-9041
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI111825)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007739, P30GM133893)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Energy (KP1607011)
- License Information
-
More Information
Article History
Received: 3 February 2023
Accepted: 3 May 2023
First Online: 18 May 2023
Competing interests
: A.G., K.S.K., and J.V.R. have submitted a patent application to the United States Patent Office pertaining to the development and characterization of IgG glycoform-specific nanobodies and methods of use (PCT/US2022/019743). The remaining authors declare no competing interests.
